Skip to content

The effect of omega-3 in the treatment of gestational diabetes

The effect of omega-3 supplementation on insulin resistance and lipid profiles in women with gestational diabetes

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT201312265623N16
Enrollment
56
Registered
2014-03-10
Start date
2014-03-03
Completion date
Unknown
Last updated
2019-10-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Gestational diabetes mellitus. Diabetes mellitus in pregnancy, unspecified

Interventions

Intervention 1: Intervention group: Magnesium tablet, 250 mg, daily for 6 weeks orally. Intervention 2: Intervention group: Omega-3 pearl, daily for 6 weeks orally. Intervention 3: Control group: Plac

Sponsors

Kashan University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to 40 Years

Inclusion criteria

Inclusion criteria: Pregnant women aged 18-40 years Diagnosed with GDM at 24-28 weeks' gestation

Exclusion criteria

Exclusion criteria: The use of substitute treatments including hormone or vitamin supplements Patients with pre-eclampsia Complete bed rest (CBR) Intra uterine fetal death (IUFD) Placenta abruption Preterm delivery

Design outcomes

Primary

MeasureTime frame
Insulin. Timepoint: At the beginning of the study and after 6 weeks of intervention. Method of measurement: Elisa kit.;Insulin resistance. Timepoint: At the beginning of the study and after 6 weeks of intervention. Method of measurement: Calculation using HOMA formula.

Secondary

MeasureTime frame
Total cholesterol. Timepoint: At the beginning of the study and after 6 weeks of intervention. Method of measurement: Enzymatic kit.;Triglycerides. Timepoint: At the beginning of the study and after 6 weeks of intervention. Method of measurement: Enzymatic kit.;HDL-cholesterol. Timepoint: At the beginning of the study and after 6 weeks of intervention. Method of measurement: Enzymatic kit.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactZatollah Asemi

Kashan University of Medical Sciences

asemi_r@yahoo.com+98 31 5546 3378

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Mar 20, 2026